| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 86661138 | FILING DATE | 06/12/2015 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MARESCA, MEREDITH Z |
L.O. ASSIGNED | 109 |
PUB INFORMATION |
|||
| RUN DATE | 09/16/2016 | ||
| PUB DATE | 03/01/2016 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 09/14/2016 | ||
| LITERAL MARK ELEMENT | ALLERGAN | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | ALLERGAN |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Allergan, Inc. |
| ADDRESS | 2525 Dupont Drive Irvine, CA 92612 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 003 |
| DESCRIPTION TEXT | House mark used for a line of cosmetic and skin soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 003 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) dark blue, medium blue, light blue, green, medium green, and yellow is/are claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of the word "ALLERGAN" in a stylized dark blue font to the left of which is a stylized futuristic comet design comprised of circles that are as follows moving from right to left: three large dark blue circles, followed next by four medium blue circles that are large on the outside with the two middle circles being smaller, followed next by three small light blue circles, followed next by three large green circles, followed next by three smaller medium green circles, followed next by three small yellow circles, with the last circle being the point of the comet. |
| OWNER OF US REG NOS | 2147765 3332859 3596709 |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 09/16/2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 023 |
| 09/14/2016 | EX1G | S | EXTENSION 1 GRANTED | 022 |
| 09/14/2016 | EXT1 | S | EXTENSION 1 FILED | 021 |
| 09/14/2016 | EEXT | I | TEAS EXTENSION RECEIVED | 020 |
| 04/26/2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 019 |
| 03/01/2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 018 |
| 03/01/2016 | PUBO | A | PUBLISHED FOR OPPOSITION | 017 |
| 02/10/2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 016 |
| 01/22/2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 015 |
| 01/22/2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 014 |
| 01/22/2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 013 |
| 01/22/2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 012 |
| 01/22/2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 011 |
| 01/20/2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 01/19/2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 01/19/2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
| 09/22/2015 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 007 |
| 09/22/2015 | GPRA | F | PRIORITY ACTION E-MAILED | 006 |
| 09/22/2015 | CPRA | R | PRIORITY ACTION WRITTEN | 005 |
| 09/22/2015 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 06/18/2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 06/17/2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 06/16/2015 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | NONE |
| CORRESPONDENCE ADDRESS | SUSAN J. HINCHEY Allergan 2525 DuPont Dr Irvine, CA 92612-1599 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Allergan, Inc. |
| ADDRESS | 2525 Dupont Drive Irvine, CA 92612 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |